Polycystic kidney disease is a genetic disorder that lacks a cure and can significantly impact an individual’s quality of life. We spoke to the American Kidney Fund regarding the challenges of diagnosis and disease management.
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explores the key challenges in mesothelioma prevention, diagnosis and treatment.
Research conducted by the University of Surrey suggests that insulin icodec, a weekly basal injection, may be just as effective when treating type 1 diabetes compared to daily basal insulin treatments.
A study has revealed that a 1 % decrease in deep sleep each year among individuals aged 60 and older can lead to a 27 % rise in the risk of developing dementia.
UK-based charity, Epilepsy Action, outlines how glioma-related epilepsy can heavily impact a person’s quality of life, drawing on the need for further research and treatment options.
Researchers aim to uncover how extreme weather affects long-term HIV care outcomes and implications for addressing climate change impacts and other chronic health conditions.
In a groundbreaking collaboration, the Accelerated Capability Environment (ACE) has teamed up with the NHS's AI Skunkworks to harness AI to diagnose Parkinsons with unprecedented speed.
A new groundbreaking blood test, p-tau217, holds potential as an Alzheimer's disease indicator. When incorporated into a two-step process, it demonstrates exceptional accuracy in detecting or ruling out brain amyloidosis, a crucial early sign.
A new study of chronic fatigue syndrome reveals how women are more severely affected by the condition and tend to develop more severe symptoms over time.
Rhett Reichard, PhD and Keri C. Smith, PhD from Saba University School of Medicine, says that while multiple sclerosis is a debilitating disease, new treatments offer hope.
Dr Nauf AlBendar, Doctor of Clinical Medicine & Founder of The Womb Effect, introduces spina bifida, the primary cause of foetal loss and substantial disabilities in newborns.
